NR3C1 and ovarian cancer: Our data (Figure 4A) demonstrate that GR activation enhances the ability of ILC spheroid cells to adhere and intercalate through a mesothelial monolayer, displacing the mesothelial cells from the ECM (fibronectin and collagen I) as described for ovarian cancer cells by Iwanicki et al. (2011) (Figure 4C) [31].